INNODIA accelerates the development of therapies to prevent and cure type 1 diabetes
- We bring together the leading experts in type 1 diabetes
- We have assembled the best-in-class network of accredited clinical trial sites in Europe
- We are the gateway to top notch professionals and research labs working on type 1 diabetes
- We provide access to a qualified community of people and families living with type 1 diabetes everywhere
How academic researchers, scientists, industry, and patients liaise together to prevent and cure type 1 diabetes.
INNODIA is the largest European Network dedicated to preventing and curing type 1 diabetes and represents the point of contact between those who want to develop new therapies and those who have the tools and experience to do so. With the aim of spurring transformational innovation in type 1 diabetes, INNODIA provides full support to SMEs, biotechs, and other entities that might otherwise not invest in Type1Diabetes R&D due to high barriers to entry and low returns.
As a matter of fact, INNODIA convenes entities often with different incentives but united in the desire to address the same unifying unmet medical need: the lack of definitive cures for people living with type 1 diabetes.